Drugs / MR2XXX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02446561 | Apr → Jul 2015 | — | Mundipharma Research Limited | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT02089581 Comparator | Apr → May 2014 | — | Mundipharma Research Limited | Completed | No outcome recorded |
| Phase 1 | NCT02133820 Comparator | Apr → Jun 2014 | — | Mundipharma Research Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MR2XXX | “MR2XXX” NCT02133820 ↗ |
| Route | Oral | “following an administration of a single oral dose” NCT02089581 ↗ |